Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hirsch

Showing results (921-930 of 1,259) with videos related to

Pageof 126
Sort By:
Cognitive Therapy and Research|October 26, 2022
Specific Pandemic-Related Worries Predict Higher Attention-Related Errors and Negative Affect Independent of Trait Anxiety in UK-Based StudentsChris R H Brown, Ya-Chun Feng, Vlad Costin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 13, 2012
Correlation between MET gene copy number by silver in situ hybridization and protein expression by immunohistochemistry in non-small cell lung cancerRafal Dziadziuszko, Murry W Wynes, Shalini Singh, et al.
Revista Paulista De Medicina|July 1, 1990
[Neuropsychiatric disorders in systemic lupus erythematosus: a multidisciplinary review]E C Miguel Filho, R M Pereira, O P de Almeida, et al.
JAMA Internal Medicine|May 24, 2013
Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials.govBradford R Hirsch, Robert M Califf, Steven K Cheng, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 27, 2013
Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancerNir Peled, Murry W Wynes, Norihiko Ikeda, et al.
Molecular Cancer|February 23, 2024
Small cells - big issues: biological implications and preclinical advancements in small cell lung cancerAnna Solta, Büsra Ernhofer, Kristiina Boettiger, et al.
Scientific Reports|January 31, 2020
Wheat dwarfing influences selection of the rhizosphere microbiomeVanessa N Kavamura, Rebekah J Robinson, David Hughes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agentsP A Bunn, B Helfrich, A F Soriano, et al.
Cancer|January 26, 2008
Epidermal growth factor receptor immunohistochemistry: comparison of antibodies and cutoff points to predict benefit from gefitinib in a phase 3 placebo-controlled study in advanced nonsmall-cell lung cancerFred R Hirsch, Rafal Dziadziuszko, Nick Thatcher, et al.
Frontiers in Oncology|September 7, 2013
A Pilot Study (SWOG S0429) of Weekly Cetuximab and Chest Radiotherapy for Poor-Risk Stage III Non-Small Cell Lung CancerYuhchyau Chen, James Moon, Kishan J Pandya, et al.
Pageof 126

Showing results (921-930 of 1,259) with videos related to

Sort By:
Pageof 126
Cognitive Therapy and Research|October 26, 2022
Specific Pandemic-Related Worries Predict Higher Attention-Related Errors and Negative Affect Independent of Trait Anxiety in UK-Based StudentsChris R H Brown, Ya-Chun Feng, Vlad Costin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 13, 2012
Correlation between MET gene copy number by silver in situ hybridization and protein expression by immunohistochemistry in non-small cell lung cancerRafal Dziadziuszko, Murry W Wynes, Shalini Singh, et al.
Revista Paulista De Medicina|July 1, 1990
[Neuropsychiatric disorders in systemic lupus erythematosus: a multidisciplinary review]E C Miguel Filho, R M Pereira, O P de Almeida, et al.
JAMA Internal Medicine|May 24, 2013
Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials.govBradford R Hirsch, Robert M Califf, Steven K Cheng, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 27, 2013
Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancerNir Peled, Murry W Wynes, Norihiko Ikeda, et al.
Molecular Cancer|February 23, 2024
Small cells - big issues: biological implications and preclinical advancements in small cell lung cancerAnna Solta, Büsra Ernhofer, Kristiina Boettiger, et al.
Scientific Reports|January 31, 2020
Wheat dwarfing influences selection of the rhizosphere microbiomeVanessa N Kavamura, Rebekah J Robinson, David Hughes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agentsP A Bunn, B Helfrich, A F Soriano, et al.
Cancer|January 26, 2008
Epidermal growth factor receptor immunohistochemistry: comparison of antibodies and cutoff points to predict benefit from gefitinib in a phase 3 placebo-controlled study in advanced nonsmall-cell lung cancerFred R Hirsch, Rafal Dziadziuszko, Nick Thatcher, et al.
Frontiers in Oncology|September 7, 2013
A Pilot Study (SWOG S0429) of Weekly Cetuximab and Chest Radiotherapy for Poor-Risk Stage III Non-Small Cell Lung CancerYuhchyau Chen, James Moon, Kishan J Pandya, et al.
Pageof 126